All but three patients were considered immunocompromised for one or more of the following reasons: uncontrolled hematological malignancy, chemotherapy, < 3 months after transplantation, prior steroid treatment, systemic immunosuppression, reduced CD4+ T-cell count, hypogammaglobulinemia. Here, CD4 is linked to hematologic disorder.